Superficial parasternal intercostal plane block with ropivacaine versus placebo for opioid exposure after cardiac surgery (EPOCH CardioLink-10): a multicentre, double-blind, randomised trial.

Alli A, Mazer CD, Dennis F, Teoh H, Chin K, Quan A, Hassan SMA, Szarek M, Tran JD, Dhingra NK, Ghiringhelli JP, de Vasconcelos Papa F, Lee Y, Ricci MJ, Verma R, Derry KL, George T, Krishnaraj A, Hess DA, Rotstein OD, Cook RC, Hassan A, Yau TM, Spence JD, Martinka PM, Sutherland K, Gregory AJ, Noss CD, de Jager P, Dougherty JL, Arora RC, Verma S

Open source

DOI
10.1016/j.lana.2026.101508
Published
2026 Aug
Container
Lancet regional health. Americas
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lana.2026.101508,
  title = {Superficial parasternal intercostal plane block with ropivacaine versus placebo for opioid exposure after cardiac surgery (EPOCH CardioLink-10): a multicentre, double-blind, randomised trial.},
  author = {Alli A and Mazer CD and Dennis F and Teoh H and Chin K and Quan A and Hassan SMA and Szarek M and Tran JD and Dhingra NK and Ghiringhelli JP and de Vasconcelos Papa F and Lee Y and Ricci MJ and Verma R and Derry KL and George T and Krishnaraj A and Hess DA and Rotstein OD and Cook RC and Hassan A and Yau TM and Spence JD and Martinka PM and Sutherland K and Gregory AJ and Noss CD and de Jager P and Dougherty JL and Arora RC and Verma S},
  year = {2026},
  journal = {Lancet regional health. Americas},
  doi = {10.1016/j.lana.2026.101508},
  url = {https://doi.org/10.1016/j.lana.2026.101508}
}

RIS

TY  - JOUR
TI  - Superficial parasternal intercostal plane block with ropivacaine versus placebo for opioid exposure after cardiac surgery (EPOCH CardioLink-10): a multicentre, double-blind, randomised trial.
AU  - Alli A
AU  - Mazer CD
AU  - Dennis F
AU  - Teoh H
AU  - Chin K
AU  - Quan A
AU  - Hassan SMA
AU  - Szarek M
AU  - Tran JD
AU  - Dhingra NK
AU  - Ghiringhelli JP
AU  - de Vasconcelos Papa F
AU  - Lee Y
AU  - Ricci MJ
AU  - Verma R
AU  - Derry KL
AU  - George T
AU  - Krishnaraj A
AU  - Hess DA
AU  - Rotstein OD
AU  - Cook RC
AU  - Hassan A
AU  - Yau TM
AU  - Spence JD
AU  - Martinka PM
AU  - Sutherland K
AU  - Gregory AJ
AU  - Noss CD
AU  - de Jager P
AU  - Dougherty JL
AU  - Arora RC
AU  - Verma S
PY  - 2026
JO  - Lancet regional health. Americas
DO  - 10.1016/j.lana.2026.101508
UR  - https://doi.org/10.1016/j.lana.2026.101508
ER  - 

APA

A, A., CD, M., F, D., H, T., K, C., A, Q., SMA, H., M, S., JD, T., NK, D., JP, G., F, D. V. P., Y, L., MJ, R., R, V., KL, D., T, G., A, K., DA, H., OD, R., RC, C., A, H., TM, Y., JD, S., PM, M., K, S., AJ, G., CD, N., P, D. J., JL, D., RC, A., & S, V. (2026). Superficial parasternal intercostal plane block with ropivacaine versus placebo for opioid exposure after cardiac surgery (EPOCH CardioLink-10): a multicentre, double-blind, randomised trial.. Lancet regional health. Americas. https://doi.org/10.1016/j.lana.2026.101508

Source records